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Abstract. A standard model for exposing structured provenance meta-
data of scientific assertions on the Semantic Web would increase interop-
erability, discoverability, reliability, as well as reproducibility for scientific
discourse and evidence-based knowledge discovery. Several Resource De-
scription Framework (RDF) models have been proposed to track prove-
nance. However, provenance metadata may not only be verbose, but
also significantly redundant. Therefore, an appropriate RDF provenance
model should be efficient for publishing, querying, and reasoning over
Linked Data. In the present work, we have collected millions of pair-
wise relations between chemicals, genes, and diseases from multiple data
sources, and demonstrated the extent of redundancy of provenance in-
formation in the life science domain. We also evaluated the suitability of
several RDF provenance models for this crowdsourced data set, including
the N-ary model, the Singleton Property model, and the Nanopublication
model. We examined query performance against three commonly used
large RDF stores, including Virtuoso, Stardog, and Blazegraph. Our ex-
periments demonstrate that query performance depends on both RDF
store as well as the RDF provenance model.
1 Introduction
Evidence and provenance are key aspects of a healthy scientific discourse. A stan-
dard model to provide structured and interoperable metadata linked to scientific
assertions is of increasing interest [22,16]. The Resource Description Framework
(RDF), the lingua franca for the Semantic Web, offers the building blocks by
which statements can be provided along with their metadata. Structured meta-
data, such as whether the resource was manually curated or automatically text
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mined from scientific literature, is key to assessing quality of information. Hence,
a scalable and well-designed RDF-based metadata model is crucial for knowledge
integration.
Specifying the provenance of a single entity can be easily achieved using ex-
isting RDF terminologies such as PROV. However, it is the specification of the
provenance of a binary or n-ary relation which remains non-standard. Several
models for exposing the provenance metadata of the relations have been pro-
posed including adding provenance annotations to i) an instance of a class that
represents the n-ary relation (N-ary model) [2]; ii) an instantiated property, i.e.
Singleton property (SP) model [18]; and iii) a graph that contains the relational
assertions, i.e. Nanopublication model [12]. In the life sciences, the N-ary model
has been used to capture the provenance information for protein-protein inter-
actions (i.e. iRefIndex database [20]) and text-mined gene-disease interactions
(i.e. DisGeNET [6]), while the recently proposed SP model [18] has been used
across elements of biomedical and material sciences. Despite their use to repre-
sent various data, no study has yet been performed to examine the advantages
and disadvantages of all these models using a common dataset.
In the present study, we aim to evaluate the consequence of using different
RDF models to capture provenance metadata for life science data. We examine
the number of triples generated and query performance on three RDF stores: Vir-
tuoso [4], StarDog [3], and BlazeGraph [1]. Regarding to the provenance meta-
data of the relational assertions, we consider the data source, the supporting
scientific publication, and the biological species where the given assertion holds
true. In addition to the three basic RDF models described above, we also ex-
amine the implementions of the so-called cardinal assertion model that was first
introduced by Nanopublications [5] on the N-ary and SP models, to create a non-
redundant network of assertions. This consideration is particularly important as
there exists substantive overlap in the assertions from multiple databases. For
instance, the asserted relation between dexamethasone (PubChem Compound
5743) and glucocorticoid receptor (GR) (NCBI Gene 2908) was mentioned by
four different data sources, but each data source cites an entirely different set
of scientific publications in support of the assertion. This work is crucial for
the efficient implementation of scalable, interoperable, and extensible knowledge
models for open data sources including PubChemRDF [10], Bio2RDF [7], and
DisGeNET RDF[19].
2 Methods
2.1 Dataset preparation
We generated a reference dataset of pairwise relations between chemicals, genes,
and diseases from multiple data sources across life science domain. The chemical-
disease relations were obtained from National Drug File Reference Terminology
(NDFRT) [8], CTD [9], KEGG [13], and SIDER [15]; chemical-gene relations
were obtained from CTD [9], DrugBank [14], KEGG [13], IUPHAR-DB [23], and
ChEMBL [11]; protein-protein relations were obtained from iRefIndex [20] and
BioGRID [24]; gene-disease were contributed by DisGeNET [6]. All chemicals
were represented using PubChem Compound identifiers (CIDs), all genes were
represented using National Center for Biotechnology Information (NCBI) Gene
identifiers (GIDs), and all diseases were represented using the Unified Medical
Language System (UMLS) Concept Unique Identifiers. The pairwise relations
were normalized using the modified Semantic Network standard vocabulary [21].
The interrelations between biomedical entities (chemicals, genes, and diseases)
constitute a semantic network, and SPARQL queries were used to explore the
network topology on behalf of evidence-based hypothesis generation. However,
it is fairly common to collect the identical assertion from multiple sources, in
particular, for such a consolidated knowledge base. Hence, additional constraints
were applied in the searching strategies.
2.2 RDF model construction
Five RDF models were studied, including N-ary model with and without cardinal
assertion (Fig. 1), SP model with and without cardinal assertion (Fig. 2), and the
Nanopublication model (Fig. 3). Only the assertion graphs and the provenance
graphs were considered in the Nanopublication model. In both N-ary and SP
cardinal assertion variants, a predicate cito:providesAssertionFor is used to
link the cardinal assertion of the pairwise relation to the multiple evidence (Fig.
1A and 2A). Without cardinal assertion, the pairwise relation would be asserted
redundantly by multiple data sources (Fig. 1B and 2B). In the Nanopublication
model variant A, one assertion graph may correspond with one or more than
one provenance graphs (Fig. 3). In the following comparative analysis, Model
I refers to the N-ary model with cardinal assertion, Model II refers to the N-
ary model without cardinal assertion, Model III refers to the SP model with
cardinal assertion, Model IV refers to the SP model without cardinal assertion,
and Model V refers to the Nanopublication model.
2.3 Query formulation
An interesting research topic in drug discovery is to determine which proteins
are responsible for eliciting particular drug side effects. We formulated SPARQL
queries to examine this question using different levels of complexity (Q1, Q2)
and provenance constraints (Q3, Q4). Q1 explores the hypothesis that if chemi-
cal A inhibits gene B, and gene B interacts with gene C, and gene C is linked to
disease D, then the above path can be used to explain the disease/adverse side
effect D caused by chemical A. It should be noted that the observed side effect
can be explained in several ways: either the aforementioned three-step indirect
paths, or the two-step indirect path involving only the chemical-gene interaction
and gene-disease associations. Therefore, we have constructed another query,
i.e. Q2, to filter out the diseases that are associated with genes that directly
interact with the given chemical. The first two queries do not take into account
the provenance metadata, and it is usually the case that only the integrated
Fig. 1. Graphical representation of N-ary model for the relation between compound
CID5743 and gene 2908: (a) with cardinal assertion (Model I); (b) without cardinal
assertion (Model II).
assertions are considered on behalf of hypothesis generation and knowledge dis-
covery. Q3 narrows down the search results by applying data source constraints.
Q4 restricts by number of aggregated evidence on Q1: such that the query only
considers the pairwise relations in the indirect path that have more than one
supporting literature references.
We carried out Q1 through Q4 on six chemicals that have extensive biomed-
ical annotations from multiple data sources: propranolol (CID4946), clotrimazole
(CID2812), mitoxantrone (CID4212), risperidone (CID5073), chlorpromazine (C-
ID2726), and haloperidol (CID3559). There are hundreds of similar compounds
in the integrated dataset and they are of key interest in the context of drug
repurposing and development.
All queries were performed against three RDF stores without further tuning:
open source Virtuoso 7.1, Stardog 2.2, and Blazegraph 1.5. The configuration
allowed up to 16 GB memory for each RDF store to run queries, which were
Fig. 2. Graphical representation of SP model for the relation between compound
CID5743 and gene 2908: (a) with cardinal assertion (Model III); (b) without cardi-
nal assertion (Model IV).
performed on cold cache. The Log10 transformations of the execution time in
millisecond were illustrated in boxplot; the averages and standard deviations
of the execution time in seconds were summarized as well in the comparative
analysis.
The data sets and the SPARQL queries are available at: http://figshare.
com/articles/Provenance_RDF_Models/1399197.
3 Results and Discussions
3.1 Data set statistics
We first compared the total number of triples that each RDF model contains. The
most efficient RDF model is SP model without cardinal assertion (Model IV),
which contains 17,239,427 triples, and the cardinal assertion of SP model (Model
Fig. 3. Graphical representation of Nanopublication model (Model V) for the relation
between compound CID5743 and gene 2908.
III) increased the total number of triples by about 14% to 19,575,298. For N-ary
models, the cardinal assertion also increased the total number of triples by about
6%, from 21,445,348 (Model II) to 22,787,218 (Model I). The N-ary model re-
quires two triples (predicates sio:has-agent and sio:has-target) to represent
the agent and target in a biological process, while the SP model maintains the
previous binary relation structure in only one triple. Hence, with the cardinal
assertion, the N-ary model (Model I) contains 3,211,920 more triples (∼ 16%) in
comparison with the SP model (Model III), and without the cardinal assertion,
the N-ary model (Model II) contains even more triples (4,205,921 triples) in
contrast to the SP model (Model IV). The Nanopublication model is the most
verbose model in this regard, which contains 27,605,782 triples distributed in
8,251,238 graphs.
We also studied the amount of evidence associated with each relational asser-
tion to illustrate the degree of redundancy with respect to the identical pairwise
relations in the life science domain. We only examine object property instances
representing the pairwise relations that were created in the SP models (Model
III and Model IV), as the degree of redundancy is same across other RDF mod-
els. The total number of unique subjects in the SP models with and without
cardinal assertion are 7,654,605 (Model III) and 4,442,685 (Model IV), respec-
tively. The difference between the two numbers accounts for the total number
of object property instances arbitrarily created for the cardinal assertions. If
there are multiple cases of evidence for a given assertion, the cardinal assertion
variant may reduce the total number of triples to express the same information,
however, if there is only one case of evidence for a given assertion, the cardinal
assertion will increase the total number of triples. Hence, whether the cardinal
assertion can reduce the total number of triples depends on the extent of re-
dundancy of the identical pairwise relations in the data set. Among 3,211,920
cardinal assertions, 2,800,124 (∼87%) of them are only associated with one evi-
dence, 238,558 (∼7%) of them are associated with two cases of evidence, 67,088
(∼2%) of them are associated with three cases of evidence, and 98,625 (∼3%)
of them are associated with more than three cases of evidence. The pairwise
relations between PubChem compound CID5694 and NCBI gene GID5465 is
associated with the most number of cases of evidence (3,096). Although there
were many redundant assertions from multiple data sources, the majority have
only one supporting evidence. Hence, the increase in the total number of triples
were largely attributable to publication assertions.
3.2 Query performance evaluation
We undertook a performance evaluation using three RDF databases (see Table
1). With Virtuoso, the SP models with and without cardinal assertion (Model III
and IV) largely outperformed the other models. Q1 and Q2 executed roughly
100 times faster on the SP models as compared to the N-ary models. Although
Model V yielded comparable performance with Model III and IV in Q1, the
additional filtering constraint made it much slower in Q2. In Q4, Model III,
IV, and V performed similarly, which are 10 times faster than Model II and
100 times faster than Model I. In general, Virtuoso performed best using the
SP models. With the Stardog RDF store, the N-ary models and the SP models
were comparable in performance, but they always outperformed Nanopublica-
tion model. In particular, when the aggregated evidence was considered in Q4,
both N-ary and SP models with and without cardinal assertion were carried
out over 10 times faster than the Nanopublication model. Using Blazegraph, the
Nanopublication model generally outperformed other models. In particular, Q1
and Q2 were carried out over 10 times faster in Model V rather than in other
models.
Without querying the provenance metadata, the models with cardinal asser-
tion (Model I and III) always yielded better performance in comparison with
the models without cardinal assertion (Model II and IV accordingly). Hence, if
we remove the redundant identical assertions from various data sources in both
N-ary and SP models, the graph traversal-like queries can be executed much
faster. If we think of conjunctive queries (i.e. graph traversal or inner join) as
performing Cartesian products, the computational costs go up exponentially as
the number of data items increase. Hence, the redundant pairwise relations cost
much more time rather than cardinal assertions in Q1 and Q2. However, if the
provenance restrictions were considered, the model without cardinal assertion
(Model II and IV) usually outperformed, except the Q3 of the SP models exe-
cuted in Stardog and Q4 of both N-ary and SP models executed in Blazegraph.
But the difference of query performance were usually small, except for the Q4
of the N-ary models executed in Virtuoso, and the Q3 of both N-ary and SP
models executed in Blazegraph. So in general, if the provenance restrictions were
considered, the models with and without cardinal assertion were comparable.
Table 1. The average execution time and standard deviation in seconds
Model Ia Model IIa Model IIIa Model IVa Model Va
Virtuoso
Q1
44.827 269.854 0.665 2.398 1.283
(±15.918) (±99.266) (±0.263) (±1.082) (±0.212)
Q2
260.337 369.635 0.535 2.375 585.52
(±253.588) (±120.482) (±0.301) (±1.083) (±193.382)
Q3
4.04 3.069 3.075 2.248 2.287
(±0.294) (±0.161) (±0.243) (±0.718) (±0.049)
Q4
352.312 14.994 2.201 1.953 2.531
(±204.483) (±11.587) (±0.028) (±0.331) (±0.054)
StarDog
Q1
1.906 5.499 3.354 16.805 21.291
(±0.214) (±0.191) (±0.783) (±13.315) (±0.621)
Q2
2.45 6.366 4.072 18.398 184.96
(±0.262) (±0.208) (±0.492) (±14.383) (±90.820)
Q3
2.738 1.291 3.834 16.463 27.537
(±0.240) (±0.068) (±0.500) (±14.277) (±1.602)
Q4
14.344 9.084 9.575 8.698 45.959
(±1.576) (±0.147) (±0.751) (±0.467) (±1.263)
Blazegraph
Q1
11.087 54.74 33.597 41.491 0.732
(±5.129) (±32.618) (±10.515) (±11.862) (±0.133)
Q2
10.853 56.599 33.469 41.099 4.215
(±4.494) (±34.590) (±10.292) (±12.697) (±1.635)
Q3
10.944 1.56 6.05 0.465 0.581
(±4.915) (±0.533) (±1.284) (±0.054) (±0.071)
Q4
83.384 117.131 74.505 89.054 80.729
(±1.612) (±2.721) (±1.570) (±1.119) (±1.436)
a The average execution times are in the first line, and the standard devia-
tions are in the second line within parenthesis; the best performance has been
highlighted in bold.
4 Conclusion
In this study, we evaluated three existing RDF models and two cardinal assertion
models for representing relations and exposing their provenance metadata. We
examined the effect of each model on overall graph size and query time execution
across three different RDF databases. Since our integrated life science dataset
contained many duplicate assertions, graph traversal can be accomplished in a
much more efficient way using the cardinal assertion. The redundant assertions
add up a lot of computational overhead when searching through the integrated
knowledge base for evidence-based hypothesis exploration. Surprisingly, we found
that each RDF store performed the best using a different provenance model. It
has been demonstrated that SPARQL queries may be executed in a RDF store
specific manner in a previous analysis [17]. Our results drew a similar conclusion
and may have contentious implications for the standardization of a provenance
model, which should ideally be software/platform/system agnostic. A more ex-
tensive analysis with larger benchmark datasets and more query patterns would
be helpful in the future study.
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